-74%

est. 2Y upside i

Series A

Powering the animal health supply chain.

Rank

#3624

Sector

Veterinary Procurement Software

Est. Liquidity

~4Y

Data Quality

Data: Medium

Vetcove operates in a specialized $3.0B veterinary procurement market with a strong competitive moat and impressive market penetration (23,000+ hospitals).

Last updated: March 10, 2026

Bull (30%)+100%

Vetcove successfully expands its 'Home Delivery' and other new services, significantly increasing revenue per practice and attracting new veterinary groups. Revenue accelerates to $20M-$25M by 2026, leading to a strategic acquisition or pre-IPO round at a valuation of $450M-$500M, delivering substantial returns for all shareholders, with common stock seeing a ~4x return on its implied current value after liquidation preferences.

Base (35%)+15%

Vetcove continues to grow steadily, expanding its platform features and maintaining its market leadership among veterinary practices. Revenue reaches ~$12M-$15M by 2026. An acquisition at around $260M provides a modest return for common shareholders after accounting for the $153M liquidation preferences.

Bear (35%)-70%

Incumbents (Covetrus, Patterson) aggressively replicate Vetcove's platform, or a new well-funded competitor emerges, leading to market share loss and slower-than-expected growth. The company struggles to raise its next round, resulting in a down round or a low acquisition price of ~$67.5M. Given the $153M liquidation preferences, common stock would be worthless.

Est. time to liquidity~3.5 years

Preference Stack Risk

severe

Investors hold $153M in liquidation preferences. At the estimated current valuation of $225M, $153M would go to preferred shareholders first, leaving $72M for common shareholders. If the exit is below $153M, common shareholders would receive nothing.

Dilution Risk

high

As a Series A1 company, Vetcove will likely require additional funding rounds before a liquidity event, which will cause further dilution for existing common shareholders.

Secondary Liquidity

none

There is no indication of active secondary markets or tender offers for Vetcove's shares.

Engineering — 6 roles

Account Management — 3 roles

Finance — 3 roles

Growth and Marketing — 3 roles

Design — 2 roles

Sales and Retention — 2 roles

Legal — 1 role

View all 24 open roles at Vetcove →

Last updated: March 10, 2026

Questions to Ask at the Interview

Strategic questions based on Vetcove's data — designed to show you've done your homework.

  • 1

    “How does Vetcove plan to maintain its supplier-agnostic advantage and network effects against potential competitive offerings from integrated incumbents like Covetrus and Patterson Veterinary, especially as they might seek to replicate your platform?”

  • 2

    “Given the current revenue of ~$8M and the goal to modernize the $3.0B US veterinary procurement industry, what are the key strategies for accelerating revenue growth to justify a significantly higher valuation for future liquidity events?”

  • 3

    “With $153M in total funding and the Series A1 round in late 2021, how does the company envision the path to a liquidity event (IPO or acquisition) within the next 3-5 years, and what are the implications for employee equity given the existing preference stack?”

Community

Valuation Sentiment

Our model estimates -74% upside. What do you think?

Anonymous. Do not share material non-public information.

Community Discussion

Comments are reviewed before they appear publicly.

0/2000

Loading comments...

Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.